1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
MatsukiyoCocokara & Co.

MatsukiyoCocokara & Co.

3088.T
MatsukiyoCocokara & Co.JP flagTokyo Stock Exchange
2,528.00
JPY
+20.50
- -
994.31BMarket Cap
MatsukiyoCocokara & Co.
3088.T
(Tokyo Stock Exchange)

Recent

price

2,528.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
1,482.52
1,548.7
1,604
1,525.46
1,501.66
1,665.8
1,676.34
1,760.47
1,836.11
1,918.06
1,768.91
1,991.9
2,252.77
2,447.77
2,598.97
2,803.52
1,234.77
Revenue per Share
25.24
35.48
39.62
41.12
35.94
55.48
63.02
71.68
79.81
85.01
70.15
93.81
96.02
125.31
133.85
139.94
63.59
Basic EPS, GAAP
25.16
46.28
48.94
64.19
10.29
78.25
57.56
72.59
52.12
60.2
66.92
78.71
112.05
103.88
164.06
133.13
- -
Free Cash Flow per Basic Share
4.97
6.8
8.16
9.9
10.04
11.66
14.78
16.69
20.26
23.36
23.36
22.57
25.06
31.72
41.2
47.31
- -
Dividend per Share
350.99
389.92
404.9
387.35
413.73
459.5
511.19
569.03
635.39
708.98
754.78
693.38
672.7
773.56
883.74
994.92
814.97
Book Value per Share
345.71
378.66
444.24
416.63
445.45
494.45
539.06
610.69
635.52
714.17
770.67
864.37
816.47
914.37
963.23
1,040.73
888.71
Tangible Book Value per Share
289
281
284
325
323
322
319
317
314
308
308
366
422
418
408
399
417
Basic Weighted Avg Shares
428,184
434,597
456,311
495,385
485,512
536,052
535,133
558,879
575,991
590,593
544,737
729,969
951,247
1,022,531
1,061,626
1,117,440
514,765
Sales/Revenue/Turnover
11.34
4.17
4.32
4.53
3.63
5.12
5.31
6.01
6.26
6.36
5.8
5.63
6.55
7.4
7.73
7.6
7.41
Operating Margin (%)
5,041
5,452
6,024
6,420
7,157
7,569
7,945
7,704
8,233
8,403
8,578
14,861
20,840
22,367
22,599
23,660
- -
Depreciation Expense
7,291
9,955
11,270
13,355
11,619
17,853
20,119
22,755
25,035
26,176
21,602
34,377
40,545
52,347
54,675
55,776
26,509
Net Income, GAAP
48.07
44.2
41.2
40.82
40.39
33.84
30.18
33.88
33
33.02
33.87
30.24
37.19
35.24
34.43
36.25
34.89
Effective Tax Rate (%)
1.7
2.29
2.47
2.7
2.39
3.33
3.76
4.07
4.35
4.43
3.97
4.71
4.26
5.12
5.15
4.99
5.15
Profit Margin (%)
14,211
20,321
20,347
26,768
30,149
45,271
58,484
72,638
77,114
73,825
90,445
155,766
176,538
191,370
201,676
219,432
179,549
Working Capital
17,918
17,706
2,428
2,752
2,662
2,742
2,710
2,996
3,905
22,176
21,719
20,280
19,298
588
607
743
- -
LT Debt
109,987
115,721
137,106
150,625
158,296
171,639
184,058
204,869
209,267
229,303
246,218
460,128
482,715
515,174
521,497
544,449
501,052
Total Equity
18.43
7.26
8.02
8.55
6.42
10.42
10.56
10.79
10.97
10.41
7.79
7.44
7.72
9.15
9.84
9.78
4.63
Return on Invested Capital (%)
5.71
7.54
8.74
10.41
8.56
12.27
12.6
12.91
12.83
11.7
8.68
12.9
13.85
16.04
15.36
14.51
7.73
Return on Capital (%)
7.4
9.45
10.04
11.08
8.95
12.68
12.94
13.24
13.18
12.54
9.59
14.13
15.07
17.24
15.98
14.73
8.24
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
20,075
- -
19,464
LT Borrowings
- -
- -
- -
LT Finance Leases
588
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
417
- -
404
Market Capitalization
1,020,199
963,022
980,949

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
370,798
- -
355,143
Cash, Cash Equivalents & STI
117,720
- -
113,394
Accounts Receivable, Net
61,747
- -
57,940
Inventories
139,352
- -
142,147
Total Current Liabilities
179,428
- -
175,594
Payables & Accruals
- -
- -
- -
ST Debt
20,075
- -
19,464
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.18%
20.83%
4.4%
Free Cash Flow
12.32%
25.87%
-20.82%
Net Income, GAAP
13.55%
22.53%
2.01%
Sales/Revenue/Turnover
8.3%
16.18%
5.26%
Total Cash Common Dividend
17.84%
21.44%
12.04%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
248,222
259,544
262,567
252,198
1,022,531
2025
- -
- -
- -
- -
1,061,626
2026
- -
- -
- -
- -
1,117,440

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
28.69
- -
- -
- -
125.31
2025
- -
- -
- -
- -
133.85
2026
- -
- -
- -
- -
139.94

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
31.72
2025
- -
- -
- -
- -
41.2
2026
- -
- -
- -
- -
47.31
Similar Companies
Trees Corporation (TREE.NE)
Inhibitor Therapeutics, Inc. (CBTE)
Dis-Chem Pharmacies Limited (DCP.JO)
Alibaba Health Information Technology Limited (ALBBY)
Ligand Pharmaceuticals Incorporated (LGNYZ)
Zenith Drugs Ltd. (ZENITHDRUG.NS)
Business
MatsukiyoCocokara & Co. oversees an extensive network of drugstores and pharmacies throughout Japan. Specializing in health, beauty products, and daily essentials, the company operates more than 2,800 retail locations nationwide. With a heritage dating back to 1932, MatsukiyoCocokara & Co. maintains its corporate headquarters in Tokyo, Japan.